Drug intelligence / Profile preview

Acellular Tissue Engineered Vessel with External Support Structure

Development stage: Unknown
Lead developer: Vascudyne
Modality: Tissue Cells → Other Cell Types → Cell Therapies, Device-based Delivery → Drug Delivery Systems
Administration: Surgical Implantation

Overview

Acellular Tissue Engineered Vessel with External Support Structure is a bioengineered vessel developed by Vascudyne, Inc. It is designed to serve as a bypass for coronary arteries, aiming to assess its safety and feasibility in patients requiring multi-vessel coronary artery bypass grafting (CABG). This device functions as a structural replacement for damaged blood vessels.

Other names: Vascudyne's Small Diameter Acellular Tissue Engineered Vessel (ATEV) for Coronary Artery Bypass

Beyond the preview

Go deeper on Acellular Tissue Engineered Vessel with External Support Structure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acellular Tissue Engineered Vessel with External Support Structure.

Explore the full profile